Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion.

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.

Thermo Fisher Scientific Inc. (NYSE:TMO) surpassed analyst expectations for the fourth quarter of 2024, reporting higher-than-anticipated earnings per share (EPS) and revenue. The company's stock rose ...

Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.

Michael Ryskin, an analyst from Bank of America Securities, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated ...

Thermo Fisher Scientific (TMO) announced earnings for its fourth quarter that increased from the same period last year and beat the ...

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

Authenticated data presented in the Life science tools market report is based on findings of extensive primary and secondary research.

An interview on how advanced techniques can be used to enhance silk fibroin and chitosan for drug delivery applications.

Real-Time PCR (qPCR) market Insights: Used extensively in diagnostics, life sciences, and environmental testing ...

Well, I was here that memorable. Press chunk that they had for the original Star Wars and at that very day I believe somebody came in and said George Lucas has given both of you guys *** little ...